HEADER TRANSFERASE 05-MAR-09 2RQ8 TITLE SOLUTION NMR STRUCTURE OF TITIN I27 DOMAIN MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: TITIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 12677-12765; COMPND 5 SYNONYM: CONNECTIN, RHABDOMYOSARCOMA ANTIGEN MU-RMS-40.14; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TTN; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PET-21A(+) KEYWDS BETA-SANDWICH, IMMUNOGLOBULIN-LIKE DOMAIN, ALTERNATIVE SPLICING, ATP- KEYWDS 2 BINDING, CALCIUM, CALMODULIN-BINDING, CARDIOMYOPATHY, COILED COIL, KEYWDS 3 CYTOPLASM, DISEASE MUTATION, DISULFIDE BOND, IMMUNOGLOBULIN DOMAIN, KEYWDS 4 ISOPEPTIDE BOND, KELCH REPEAT, KINASE, LIMB-GIRDLE MUSCULAR KEYWDS 5 DYSTROPHY, MAGNESIUM, METAL-BINDING, NUCLEOTIDE-BINDING, NUCLEUS, KEYWDS 6 PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE, TPR KEYWDS 7 REPEAT, TRANSFERASE, UBL CONJUGATION, WD REPEAT EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.YAGAWA,T.OGURO,T.MOMOSE,S.KAWANO,T.SATO,T.ENDO REVDAT 2 10-NOV-21 2RQ8 1 REMARK SEQADV REVDAT 1 02-FEB-10 2RQ8 0 JRNL AUTH K.YAGAWA,K.YAMANO,T.OGURO,M.MAEDA,T.SATO,T.MOMOSE,S.KAWANO, JRNL AUTH 2 T.ENDO JRNL TITL STRUCTURAL BASIS FOR UNFOLDING PATHWAY-DEPENDENT STABILITY JRNL TITL 2 OF PROTEINS: VECTORIAL UNFOLDING VS. GLOBAL UNFOLDING JRNL REF PROTEIN SCI. 2010 JRNL REFN ESSN 1469-896X JRNL PMID 20095049 JRNL DOI 10.1002/PRO.346 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 2.1 REMARK 3 AUTHORS : P.GUNTERT ET AL. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2RQ8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-MAR-09. REMARK 100 THE DEPOSITION ID IS D_1000150154. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : 50MM POTASSIUM PHOSPHATE REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1.0MM TITIN I27 MUTANT, 50MM REMARK 210 POTASSIUM PHOSPHATE BUFFER, 99.9% REMARK 210 D2O; 1.0MM [U-15N] TITIN I27 REMARK 210 MUTANT, 50MM POTASSIUM PHOSPHATE REMARK 210 BUFFER, 90% H2O/10% D2O; 1.0MM REMARK 210 [U-13C; U-15N] TITIN I27 MUTANT, REMARK 210 50MM POTASSIUM PHOSPHATE BUFFER, REMARK 210 99.9% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 3D 1H-15N NOESY; REMARK 210 3D 1H-13C NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLU A 17 -94.83 -131.15 REMARK 500 1 GLU A 27 83.17 -156.37 REMARK 500 1 ASN A 62 77.52 64.28 REMARK 500 1 CYS A 63 69.86 -100.30 REMARK 500 1 ALA A 76 72.37 59.00 REMARK 500 1 LEU A 89 101.82 -59.13 REMARK 500 1 GLU A 91 35.57 -97.64 REMARK 500 2 PRO A 7 -170.99 -69.80 REMARK 500 2 GLU A 17 -93.54 -130.56 REMARK 500 2 GLU A 27 84.28 -152.03 REMARK 500 2 ASP A 29 35.69 -93.88 REMARK 500 2 ASN A 62 81.01 64.31 REMARK 500 2 CYS A 63 72.65 -108.37 REMARK 500 2 LEU A 65 30.54 -143.88 REMARK 500 2 ALA A 76 71.31 63.95 REMARK 500 3 GLU A 17 -101.12 -130.99 REMARK 500 3 GLU A 27 84.29 -166.74 REMARK 500 3 CYS A 63 32.47 -95.16 REMARK 500 3 GLN A 64 -169.43 -60.25 REMARK 500 3 ALA A 76 71.84 58.81 REMARK 500 3 LEU A 89 103.82 -52.99 REMARK 500 3 HIS A 93 55.11 -90.48 REMARK 500 4 ILE A 2 92.48 -64.96 REMARK 500 4 LYS A 6 76.54 -156.54 REMARK 500 4 PRO A 7 -178.60 -69.76 REMARK 500 4 GLU A 17 -95.36 -125.93 REMARK 500 4 THR A 68 121.14 66.75 REMARK 500 4 ALA A 76 71.81 56.60 REMARK 500 5 LYS A 6 79.56 -152.28 REMARK 500 5 PRO A 7 -178.14 -69.75 REMARK 500 5 GLU A 17 -96.83 -131.10 REMARK 500 5 GLU A 27 84.94 -156.08 REMARK 500 5 ASN A 62 70.85 61.29 REMARK 500 5 CYS A 63 65.16 -101.93 REMARK 500 5 THR A 68 125.70 67.93 REMARK 500 5 ALA A 76 71.67 60.42 REMARK 500 6 LEU A 1 139.17 -170.96 REMARK 500 6 LYS A 6 83.70 -150.19 REMARK 500 6 PRO A 7 -173.68 -69.79 REMARK 500 6 GLU A 17 -93.31 -109.51 REMARK 500 6 GLN A 64 88.29 -67.80 REMARK 500 6 ALA A 76 70.93 61.36 REMARK 500 6 LEU A 90 116.65 -170.57 REMARK 500 7 GLU A 17 -93.61 -130.25 REMARK 500 7 GLU A 27 85.67 -153.27 REMARK 500 7 ASN A 62 76.63 64.29 REMARK 500 7 LEU A 65 77.13 -155.29 REMARK 500 7 LEU A 90 110.50 -171.89 REMARK 500 7 HIS A 94 -66.82 -98.68 REMARK 500 8 GLU A 17 -105.43 -131.07 REMARK 500 REMARK 500 THIS ENTRY HAS 145 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TIT RELATED DB: PDB REMARK 900 ENTRY CONTAINS WT STRUCTURE FOR THIS DEPOSITION STRUCTURE DBREF 2RQ8 A 1 89 UNP Q8WZ42 TITIN_HUMAN 12677 12765 SEQADV 2RQ8 MET A 0 UNP Q8WZ42 EXPRESSION TAG SEQADV 2RQ8 GLU A 3 UNP Q8WZ42 LYS 12679 ENGINEERED MUTATION SEQADV 2RQ8 PRO A 9 UNP Q8WZ42 TYR 12685 ENGINEERED MUTATION SEQADV 2RQ8 ALA A 42 UNP Q8WZ42 THR 12718 ENGINEERED MUTATION SEQADV 2RQ8 THR A 78 UNP Q8WZ42 ALA 12754 ENGINEERED MUTATION SEQADV 2RQ8 LEU A 90 UNP Q8WZ42 EXPRESSION TAG SEQADV 2RQ8 GLU A 91 UNP Q8WZ42 EXPRESSION TAG SEQADV 2RQ8 HIS A 92 UNP Q8WZ42 EXPRESSION TAG SEQADV 2RQ8 HIS A 93 UNP Q8WZ42 EXPRESSION TAG SEQADV 2RQ8 HIS A 94 UNP Q8WZ42 EXPRESSION TAG SEQADV 2RQ8 HIS A 95 UNP Q8WZ42 EXPRESSION TAG SEQADV 2RQ8 HIS A 96 UNP Q8WZ42 EXPRESSION TAG SEQADV 2RQ8 HIS A 97 UNP Q8WZ42 EXPRESSION TAG SEQRES 1 A 98 MET LEU ILE GLU VAL GLU LYS PRO LEU PRO GLY VAL GLU SEQRES 2 A 98 VAL PHE VAL GLY GLU THR ALA HIS PHE GLU ILE GLU LEU SEQRES 3 A 98 SER GLU PRO ASP VAL HIS GLY GLN TRP LYS LEU LYS GLY SEQRES 4 A 98 GLN PRO LEU ALA ALA SER PRO ASP CYS GLU ILE ILE GLU SEQRES 5 A 98 ASP GLY LYS LYS HIS ILE LEU ILE LEU HIS ASN CYS GLN SEQRES 6 A 98 LEU GLY MET THR GLY GLU VAL SER PHE GLN ALA ALA ASN SEQRES 7 A 98 THR LYS SER ALA ALA ASN LEU LYS VAL LYS GLU LEU LEU SEQRES 8 A 98 GLU HIS HIS HIS HIS HIS HIS SHEET 1 A 4 VAL A 11 PHE A 14 0 SHEET 2 A 4 LYS A 79 LYS A 87 1 O LYS A 85 N VAL A 13 SHEET 3 A 4 THR A 68 ALA A 75 -1 N PHE A 73 O SER A 80 SHEET 4 A 4 GLY A 32 LYS A 35 -1 N GLN A 33 O GLN A 74 SHEET 1 B 3 THR A 18 ILE A 23 0 SHEET 2 B 3 LYS A 55 HIS A 61 -1 O LEU A 60 N ALA A 19 SHEET 3 B 3 CYS A 47 ASP A 52 -1 N ILE A 50 O ILE A 57 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1